Odds
Yes98%
Market details
Status
void
Positions
8
Volume
350 cr
Locks
Dec 29, 2025
Updated
Dec 24, 2025, 03:05 AM
Rules summary
Resolves YES if US WAC annualized price for Lantus (insulin glargine) is within [$2,000, $3,200] as of Dec 31, 2026 (inclusive). Primary source: sponsor WAC/list price publication or a clearly cited WAC source. Otherwise NO.
Market context
Example drug pricing market (range-style). Use the exact source hierarchy in the rules to resolve.
People are also buying
Browse
Community vote50% Yes · 0 votes
VoteVoting closed